Literature DB >> 8175957

Acute growth hormone effects on amino acid and lipid metabolism.

K C Copeland1, K S Nair.   

Abstract

The anabolic actions of GH are well known, although specific tissue responses and the mechanism of nitrogen conservation are less well understood. This study was designed to examine the acute metabolic effects of GH on whole body and regional protein metabolism, using an experimental protocol which controlled for confounding perturbations in other hormones by a simultaneous infusion of somatostatin. Control subjects received replacement doses of insulin, glucagon, and GH for the entire 7-h study period, whereas GH subjects received an identical protocol, except for an increased dose of GH sufficient to increase serum concentrations into the high-physiological range (12-20 ng/mL) for the final 3.5 h of the study (P < 0.001). Thirteen young, healthy male subjects were studied in the postabsorptive period; five served as control subjects and eight as treatment (GH) subjects. Each received continuous iv infusions of somatostatin, L-[13-C]leucine, and L-[2H5]phenylalanine throughout the study. Femoral arterial and venous sampling allowed for simultaneous measurements across the leg and in the whole body. C-Peptide levels were suppressed throughout the infusion; insulin, glucagon, insulin-like growth factor I, cortisol, epinephrine, norepinephrine, and glucose concentrations were not different between groups. Glycerol concentrations increased 3-fold in GH subjects during the final 3.5-h period (P = 0.04). Concentrations of several amino acids declined through the study, but no differences were observed between treatment groups. Leucine oxidation was reduced in GH compared to control subjects (P = 0.04). No changes in CO2 production or whole body leucine or phenylalanine flux were observed, whereas nonoxidative disposal of leucine was marginally higher in GH compared to control subjects (P = 0.07). By contrast, rates of appearance and disappearance of both leucine and phenylalanine across the leg all were relatively lower in GH compared to control subjects; leucine balance across the leg was reduced by GH (P = 0.03), whereas phenylalanine balance was not influenced by GH. Our data thus demonstrate an acute stimulatory effect of GH on lipolysis, a decrease in leucine oxidation, and no stimulation of muscle protein synthesis in spite of enhanced protein synthesis in nonmuscle tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175957     DOI: 10.1210/jcem.78.5.8175957

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Growth hormone therapy is safe and effective in patients with lysinuric protein intolerance.

Authors:  Harri Niinikoski; Risto Lapatto; Matti Nuutinen; Laura Tanner; Olli Simell; Kirsti Näntö-Salonen
Journal:  JIMD Rep       Date:  2011-06-22

5.  Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.

Authors:  G Garibotto; A Barreca; R Russo; A Sofia; P Araghi; A Cesarone; M Malaspina; F Fiorini; F Minuto; A Tizianello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

6.  No effect of growth hormone administration on substrate oxidation during exercise in young, lean men.

Authors:  Mette Hansen; Rikke Morthorst; Benny Larsson; Rolf Dall; Allan Flyvbjerg; Michael Højby Rasmussen; Hans Orskov; Michael Kjaer; Kai Henrik Wiborg Lange
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

7.  Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children.

Authors:  Colin P Hawkes; Adda Grimberg; Vivian E Dzata; Diva D De Leon
Journal:  Horm Res Paediatr       Date:  2016-03-17       Impact factor: 2.852

8.  Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged.

Authors:  A Aarsland; D Chinkes; R R Wolfe; R E Barrow; S O Nelson; E Pierre; D N Herndon
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

9.  Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.

Authors:  T L Bianda; M A Hussain; A Keller; Y Glatz; O Schmitz; J S Christiansen; K G Alberti; E R Froesch
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

10.  Enhancement of muscle mitochondrial function by growth hormone.

Authors:  Kevin R Short; Niels Moller; Maureen L Bigelow; Jill Coenen-Schimke; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.